This Week Health

Interviews in Action

More
Browse by Topic
Cybersecurity
AI/Machine Learning
Clinician Burnout
Cybersecurity
AI & Machine
Learning
John Halamka This Week in Health IT
John Halamka on Cloud and Machine Learning, CIO as Convener, CMS Big Announcements
Read to Episode
1 687 688 689
Clinician Burnout
Podcast by Topic
R25 - Podcasts Category Filter-2
  • All
  • Leadership (674)
  • Emerging Technology (500)
  • Security (310)
  • Patient Experience (298)
  • Interoperability (296)
  • Financial (289)
  • Analytics (182)
  • Telehealth (175)
  • Digital (164)
  • Clinician Burnout (160)
  • Legal & Regulatory (141)
  • AI (104)
  • Cloud (92)
In the News

Year Two of the AI Revolution: What to Expect for GenAI in 2024 - Workflow™

February 23, 2024

In 2023, generative AI emerged as a powerful force in the business world, drawing significant investment and interest for its advanced predictive capabilities based on large learning models (LLMs). The technology's ability to understand context and predict subsequent parts of a conversation marked a notable evolution from earlier chatbots. Investment in generative AI was robust, with companies pouring nearly $16 billion into the technology, and projections by Bloomberg Insights expect spending to soar to $1.3 trillion by 2032. Despite the considerable hype and rapid growth, experts predict that the generative AI sector won't experience a downturn in the immediate future, as enterprises are poised to further develop infrastructure and refine LLMs for enhanced performance.

Heading into 2024, industry thought leaders, including Brian Solis from ServiceNow, predict that generative AI will continue to disrupt traditional business models and drive innovation. While change in legacy businesses tends to be slow, the pressure to evolve persists as disruptive technologies like generative AI challenge conventional processes and mindsets. December 2024 may not look drastically different from the previous year, but the implementation of generative AI is expected to automate existing processes and, more importantly, sow the seeds for transformative business models. Solis emphasizes the division between companies that merely use generative AI and those that leverage it to create new possibilities, suggesting that this is a critical moment for establishing new market leaders and redefining what it means to be a business in the modern era.

Year Two of the AI Revolution: What to Expect for GenAI in 2024 - Workflow™ ServiceNow

Read More

Career Guide In Digital Health And Healthcare AI

February 23, 2024

Career guide for digital health and healthcare AI fields, offering advice for researchers, those with a medical or tech background, traditional med-tech to digital health transitions, and biomedical engineers. Suggestions include finding niche research areas, understanding the technology you're working with, developing patient-focused solutions, comprehending digital health fundamentals, and improving communication skills. Being driven by passion rather than following top lists is recommended.

Career Guide In Digital Health And Healthcare AI LinkedIn

Read More

ChatGPT suddenly starts sending alarming messages to users

February 23, 2024

ChatGPT, an AI tool, started providing users with incomprehensible and alarming responses, speaking in mixed languages and implying it is physically present. User queries received nonsensical replies and some users reported disturbing responses. The issue is being investigated by OpenAI, with no known cause yet. This instance of AI behavior change recalls similar complaints from end of last year.

ChatGPT suddenly starts sending alarming messages to users Independent

Read More

Musk claims Neuralink patient doing OK with implant, can move mouse with brain

February 23, 2024

First human implanted with Neuralink's brain chip can move mouse cursor by thinking. Musk announced progress, revealed ongoing focus on initiating more button presses by thought. Neuralink's information release method criticized for lack of scientific rigor and ethical considerations. Critics argue for more detailed public disclosure and addressing potential false hope for people with serious neurological disabilities. First human trials approved by FDA despite previous concerns.

Musk claims Neuralink patient doing OK with implant, can move mouse with brain Ars Technica

Read More
View All
Insights by Kate Gamble
View All
Our Partners

Premier

Diamond Partners

Platinum Partners

Silver Partners

This Week Health
Healthcare Transformation Powered by Community
Looking to connect or attend events? Visit our sister organization, 229 Project
Click here.

© Copyright 2024 Health Lyrics All rights reserved